General MedicationsTOPICALStandard
MUPIROCIN
MUPIROCIN CALCIUM
Standard Dose
EQ 2% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MUPIROCIN is listed in Drugs@FDA under application 214811 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MUPIROCIN CALCIUM Form and strength CREAM;TOPICAL - EQ 2% BASE Sponsor AMNEAL Submission history Latest submission status date: 2022-11-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview MUPIROCIN is listed in Drugs@FDA under application 214811 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MUPIROCIN CALCIUM Form and strength CREAM;TOPICAL - EQ 2% BASE Sponsor AMNEAL Submission history Latest submission status date: 2022-11-15 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.